Context Hypercalcemia of malignancy (HCM) in patients with advanced cancer is often caused by excessive osteoclast-mediated bone resorption. Patients may not respond to or may relapse after iv bisphosphonate therapy.Objective We investigated whether denosumab, a potent inhibitor of osteoclast-mediat...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!